MedTrace Logo

Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome

NCT01033266 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2020-04-14

No results posted yet for this study

Summary

Nasal CPAP will improve cardiopulmonary exercise test (CPET) performance in patients with overlap syndrome(COPD and OSA). Nasal CPAP is proven to improve cardiopulmonary exercise testing in patients with OSA. The investigators hypothesis is that patients with overlap syndrome will have a greater improvement in their cardiopulmonary exercise testing besides a possible improvement in their lung function test and airway resistance.

Conditions

Interventions

DIAGNOSTIC_TEST

CPET

CPET will be done on patients with overlap syndrome before and after clinical CPAP treatment.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Gary Kinasewitz, MD · University of Oklahoma

  • Houssein Youness, MD · University of Oklahoma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-01
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01033266 on ClinicalTrials.gov